FrancophonIA/ELRC3.0 huggingface dataset:
English: A second resistance mechanism is encoded by a plasmid-borne and transposon associated chloramphenicol-florfenicol resistance (cfr) gene, conferring resistance in staphylococci and enterococci to oxazolidinones, phenicols, lincosamides, pleuromutilins, streptogramin A and 16membered macrolides.
Croatian: Drugi mehanizam rezistencije je kodiran genom za rezistenciju na kloramfenikol-florfenikol (cfr) koji se nalazi na plazmidu, a povezan je s transpozonom, što dovodi do rezistencije na oksazolidinone, fenikole, linkozamide, pleuromutiline, streptogramin A i 16-člane makrolide u stafilokoka i enterokoka.
English: Important: Please refer to the Summary of Product Characteristics (SmPC) before prescribing.
Croatian: Važno: Pogledajte Sažetak opisa svojstava lijeka prije propisivanja.
English: Repeated oral and intravenous dosing of tedizolid phosphate in rats in 1-month and 3-month toxicology studies produced dose- and time-dependent bone marrow hypocellularity (myeloid, erythroid, and megakaryocyte), with associated reduction in circulating RBCs, WBCs, and platelets.
Croatian: Ponovljeno peroralno i intravensko doziranje tedizolidfosfata u štakora u jednomjesečnim i tromjesečnim ispitivanjima toksičnosti prouzročilo je hipocelularnost koštane srži (mijeloidnu, eritroidnu i megakariocitnu) ovisnu o dozi i vremenu, s povezanim smanjenjem cirkulirajućih crvenih krvnih stanica, bijelih krvnih stanica i trombocita.
English: If you forget to take your medicine, take the dose as soon as possible anytime up to 8 hours prior to the next scheduled dose.
Croatian: Zaboravite li uzeti lijek, uzmite dozu što prije, u bilo koje vrijeme najkasnije do 8 sati prije sljedeće planirane doze.
English: How to take Sivextro
Croatian: Kako uzimati Sivextro
English: • Acid reflux disease (heartburn, pain or difficulty swallowing), flatulence/passing wind
Croatian: • refluksna bolest uzrokovana povratom kiseline (žgaravica, bol ili otežano gutanje), vjetrovi
English: Multiple sulfotransferase (SULT) isoforms (SULT1A1, SULT1A2, and SULT2A1) were identified in vitro that are capable of conjugating tedizolid which suggests that no single isozyme is critical to the clearance of tedizolid.
Croatian: In vitro su bili utvrđeni višestruki izooblici sulfotransferaze (SULT1A1, SULT1A2 i SULT2A1) koji mogu konjugirati tedizolid, što ukazuje da nijedan od tih enzima nije sam ključan za klirens tedizolida.
English: Adverse reactions are classified by preferred term and System Organ Class, and by frequency.
Croatian: Nuspojave su klasificirane prema preporučenom pojmu i klasifikaciji organskih sustava te prema učestalosti.
English: A clinical study comparing the single dose (2 mg) pharmacokinetics of midazolam (CYP3A4 substrate) alone or in combination with tedizolid phosphate (once-daily 200 mg oral dose for 10 days), demonstrated no clinically meaningful difference in midazolam Cmax or AUC.
Croatian: Kliničko ispitivanje u kojem se usporedila farmakokinetika jedne doze (2 mg) midazolama (supstrata CYP3A4) primijenjenog samog ili u kombinaciji s tedizolidfosfatom (oralna doza od 200 mg jedanput na dan tijekom 10 dana) pokazalo je da nema klinički značajne razlike u Cmax ili AUC midazolama.
English: Certain side effects have been observed with another member of the oxazolidinone class when administered over a duration exceeding that recommended for Sivextro.
Croatian: Određene nuspojave primijećene su kod liječenja drugim lijekom iz skupine oksazolidinona kada je trajanje primjene bilo duže od onog preporučenog za Sivextro.
English: Drug metabolizing enzymes
Croatian: Enzimi koji metaboliziraju lijek
English: • Abnormal smelling urine, abnormal blood tests
Croatian: • neuobičajen miris mokraće, odstupanja u rezultatima krvnih pretraga
English: What you need to know before you are given Sivextro
Croatian: Što morate znati prije nego počnete dobivati Sivextro
English: Irritability Pyrexia
Croatian: bol na mjestu infuzije razdražljivost pireksija
English: Type I (10 ml) clear borosilicate tubing glass vial with a siliconised grey chlorobutyl rubber stopper.
Croatian: I od 10 ml sa sivim čepom od silikonizirane klorobutilne gume.
English: Recommended dose and duration The recommended dosage is 200 mg once daily for 6 days.
Croatian: Preporučena doza je 200 mg jedanput na dan tijekom 6 dana.
English: Sivextro 200 mg powder for concentrate for solution for infusion
Croatian: Sivextro 200 mg prašak za koncentrat za otopinu za infuziju
English: Sivextro 200 mg film-coated tablets
Croatian: Sivextro 200 mg filmom obložene tablete
English: Alternative therapies should be considered when treating patients with neutropenia and ABSSSI (see section 5.1).
Croatian: Potrebno je razmotriti druge terapije prilikom liječenja bolesnika s neutropenijom i akutnom bakterijskom infekcijom kože i kožnih struktura (vidjeti dio 5.1).
English: Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment)
Croatian: 6.1 Popis pomoćnih tvari manitol natrijev hidroksid (za podešavanje pH) kloridna kiselina (za podešavanje pH)
English: If less than 8 hours remains before the next dose, then wait until the next scheduled dose.
Croatian: Ako je do sljedeće doze ostalo manje od 8 sati, tada pričekajte do sljedeće planirane doze.
English: If a dose is missed, it should be taken as soon as possible anytime up to 8 hours prior to the next scheduled dose.
Croatian: Propusti li se doza lijeka, treba je uzeti što prije, u bilo koje vrijeme do najkasnije 8 sati prije sljedeće planirane doze.
English: These events have been observed with another member of the oxazolidinone class when administered over a duration exceeding that recommended for tedizolid phosphate.
Croatian: Ti su događaji primijećeni kod liječenja drugim lijekom iz skupine oksazolidinona u trajanju dužem od preporučenog za tedizolidfosfat.
English: After reconstitution each ml contains 50 mg tedizolid phosphate.
Croatian: Nakon rekonstitucije, jedan ml sadrži 50 mg tedizolidfosfata.
English: The Cmax and AUC of tedizolid increased approximately dose proportionally within the single oral dose range of 200 mg to 1,200 mg and across the intravenous dose range of 100 mg to 400 mg. Steady-state concentrations are achieved within 3 days and indicate modest active substance accumulation of approximately 30%
Croatian: Cmax i AUC tedizolida rasli su približno proporcionalno dozi unutar raspona jednokratne peroralne doze od 200 mg do 1200 mg i u rasponu jednokratne intravenske doze od 100 mg do 400 mg.
English: CDAD may range in severity from mild diarrhoea to fatal colitis.
Croatian: CDAD može u rasponu po težini poprimiti oblik od blagog proljeva do kolitisa sa smrtnim ishodom.
English: Vulvovaginal mycotic infection Fungal infection Vulvovaginal candidiasis Abscess
Croatian: Infekcije i infestacije vulvovaginalna mikoza gljivična infekcija vulvovaginalna kandidijaza apsces kolitis uzrokovan Clostridioides difficile dermatofitoza kandidijaza usne šupljine infekcija dišnih puteva
English: Tedizolid is a reversible inhibitor of MAO in vitro; however, no interaction is anticipated when comparing the IC50 and the anticipated plasma exposures in man. No evidence of MAO-A inhibition was observed in Phase 1 studies specifically designed to investigate the potential for this interaction.
Croatian: Tedizolid je reverzibilan inhibitor monoaminoksidaze (MAO) in vitro; međutim, ne očekuju se interakcije kada se uspoređuje IC50 za inhibiciju MAO-A s očekivanim izloženostima u plazmi ljudi.
English: For administration, the reconstituted solution must be further diluted in 250 mL 0.9% sodium chloride.
Croatian: Za primjenu, rekonstituirana otopina mora se dodatno razrijediti u 250 ml 0,9%-tne otopine natrijevog klorida.
English: How to store Sivextro
Croatian: Kako čuvati Sivextro
English: Monoamine oxidase inhibitors
Croatian: Inhibitori monoaminoksidaze
English: Each film-coated tablet contains 200 mg tedizolid phosphate.
Croatian: Jedna filmom obložena tableta sadrži 200 mg tedizolidfosfata.
English: Urine odor abnormal
Croatian: Poremećaji bubrega i mokraćnog sustava neuobičajeni miris urina
English: Adrenergic agents
Croatian: Adrenergički lijekovi
English: If a dose is missed it should be given to the patient as soon as possible anytime up to 8 hours prior to the next scheduled dose.
Croatian: Propusti li se doza lijeka, bolesnik je mora dobiti čim prije, u bilo koje vrijeme, do najkasnije 8 sati prije sljedeće planirane doze.
English: The highest single dose administered in clinical studies was 1,200 mg. All adverse reactions at this dose level were mild or moderate in severity.
Croatian: Najviša primijenjena jednostruka doza u kliničkim ispitivanjima bila je 1200 mg.
English: If less than 8 hours remains before the next dose, then the physician should wait until the next scheduled dose.
Croatian: Ako je do sljedeće doze ostalo manje od 8 sati, tada liječnik mora pričekati do sljedeće planirane doze.
English: Reproductive system and breast disorders
Croatian: Poremećaji reproduktivnog sustava i dojki vulvovaginalni svrbež
English: For administration, the reconstituted solution must be further diluted in 250 mL of sodium chloride 0.9% solution for injection.
Croatian: Za primjenu, rekonstituirana otopina mora se dodatno razrijediti u 250 ml 0,9%-tne otopine natrijevog klorida za injekciju.
English: How you will be given Sivextro
Croatian: Kako ćete dobivati Sivextro
English: Sivextro 200 mg tablets tedizolid phosphate
Croatian: Sivextro 200 mg tablete tedizolidfosfat
English: If less than 8 hours remains before the next dose, then the patient should wait until the next scheduled dose.
Croatian: Ako je do sljedeće doze ostalo manje od 8 sati, tada bolesnik mora pričekati do sljedeće planirane doze.
English: • Infusion reactions (chills, shaking or shivering with fever, muscle pain, swelling of the face, weakness, fainting, shortness of breath, chest tightness and angina pectoris).
Croatian: • reakcije na infuziju (zimica, tresenje ili drhtanje s vrućicom, bol u mišićima, oticanje lica,
English: • Joint pain, muscle spasms, back pain, neck pain, pain/discomfort in limbs, decrease of grip strength
Croatian: • bol u zglobovima, grčevi u mišićima, bol u leđima, bol u vratu, bol/nelagoda u udovima,
English: Dysgeusia Tremor Paraesthesia Hypoaesthesia
Croatian: Poremećaji živčanog sustava glavobolja somnolencija omaglica disgeuzija tremor parestezija hipoestezija
English: OUTER CARTON (VIAL)
Croatian: KUTIJA (BOČICA)
English: In a clinical study comparing the single dose (2 mg) pharmacokinetics of midazolam (CYP3A4 substrate) alone or in combination with tedizolid phosphate (once-daily 200 mg oral dose for 10 days), midazolam AUC and Cmax when co-administered with tedizolid phosphate were 81% and 83% of midazolam AUC and Cmax when administered alone, respectively.
Croatian: U kliničkom ispitivanju u kojem se usporedila farmakokinetika jedne doze (2 mg) midazolama (supstrat CYP3A4) primijenjenog samog ili u kombinaciji s tedizolidfosfatom (oralna doza od 200 mg jedanput na dan tijekom 10 dana), AUC midazolama uz istodobnu primjenu tedizolidfosfata iznosio je 81% vrijednosti AUC-a kada je primijenjen samo midazolam, dok je Cmax uz istodobnu primjenu tedizolidfosfata iznosio 83% vrijednosti Cmax kada je primijenjen samo midazolam.
English: Infusion related reaction Peripheral oedema
Croatian: Manje često reakcija povezana s infuzijom periferni edem
English: In a clinical study comparing the single dose (10 mg) pharmacokinetics of rosuvastatin (BCRP substrate) alone or in combination with the oral administration of tedizolid phosphate 200 mg, rosuvastatin AUC and Cmax increased by approximately 70% and 55%, respectively, when coadministered with Sivextro.
Croatian: U kliničkom ispitivanju u kojem se usporedila farmakokinetika jedne doze (10 mg) rosuvastatina (supstrata BCRP-a) primijenjenog samog ili u kombinaciji s peroralno primijenjenim tedizolidfosfatom od 200 mg, AUC rosuvastatina povećao se za približno 70%, a Cmax za približno 55% kada se primijenio istodobno s lijekom Sivextro.
English: Talk to your doctor or nurse before being given Sivextro if any of the following apply to you: - are suffering from diarrhoea, or have suffered from diarrhoea whilst (or up to 2 months after) being treated with antibiotics in the past.
Croatian: Obratite se svom liječniku ili medicinskoj sestri prije nego uzmete Sivextro ako se bilo koje od sljedećeg odnosi na Vas: - ako imate proljev, ili ste dobili proljev u prošlosti za vrijeme uzimanja antibiotika (ili najviše 2 mjeseca nakon toga); - ako ste alergični na druge lijekove koji pripadaju skupini „oksazolidinona“ (na primjer linezolid, cikloserin); - ako uzimate određene lijekove za liječenje depresije poznate kao triciklički antidepresivi, selektivni inhibitori ponovne pohrane serotonina (SSRI) ili inhibitori monoaminoksidaze (MAO).
English: Each vial of powder contains disodium tedizolid phosphate which is equal to 200 mg of tedizolid phosphate.
Croatian: Jedna bočica praška sadrži dinatrijev tedizolidfosfat što odgovara 200 mg tedizolidfosfata.
English: Sivextro 200 mg film-coated tablets tedizolid phosphate
Croatian: Sivextro 200 mg filmom obložene tablete tedizolidfosfat
English: Sivextro 200 mg powder for concentrate tedizolid phosphate
Croatian: Sivextro 200 mg prašak za koncentrat tedizolidfosfat i.v.
English: • Nausea
Croatian: • umor
English: Each vial contains disodium tedizolid phosphate corresponding to 200 mg tedizolid phosphate.
Croatian: Jedna bočica sadrži dinatrijev tedizolidfosfat što odgovara 200 mg tedizolidfosfata.
English: The Cmax and AUC of tedizolid increased approximately dose proportionally within the single oral dose range of 200 mg to 1,200 mg and across the intravenous dose range of 100 mg to 400 mg. Steady-state concentrations are achieved within 3 days and indicate modest active substance accumulation of approximately 30% following multiple once-daily oral or intravenous administration as predicted by a half-life of approximately 12 hours.
Croatian: Koncentracije u stanju dinamičke ravnoteže dostižu se unutar 3 dana i ukazuju na umjerenu akumulaciju djelatne tvari od približno 30% nakon višestrukih peroralnih ili intravenskih primjena jednom dnevno kao što je i predviđeno na temelju poluvijeka od približno 12 sati.
English: Immune system disorders
Croatian: Poremećaji imunološkog sustava preosjetljivost na lijek
English: Vulvovaginal pruritus
Croatian: Prijavljivanje nuspojava
English: Sivextro 200 mg powder for concentrate for solution for infusion tedizolid phosphate
Croatian: Sivextro 200 mg prašak za koncentrat za otopinu za infuziju tedizolidfosfat
English: In a clinical study comparing the single dose (10 mg) pharmacokinetics of rosuvastatin (Breast Cancer Resistant Protein [BCRP] substrate) alone or in combination with tedizolid phosphate (once-daily 200 mg oral dose), rosuvastatin AUC and Cmax increased by approximately 70% and 55%, respectively, when coadministered with tedizolid phosphate.
Croatian: Breast Cancer Resistance Protein, BCRP]) primijenjenog samog ili u kombinaciji s tedizolidfosfatom (oralna doza od 200 mg jedanput na dan), AUC rosuvastatina povećao se za približno 70%, a Cmax za približno 55% pri istodobnoj primjeni tedizolidfosfata.
English: Crospovidone Magnesium stearate
Croatian: Jezgra tablete celuloza, mikrokristalična manitol povidon krospovidon magnezijev stearat
English: Diabetes mellitus inadequate control
Croatian: Poremećaji metabolizma i prehrane dehidracija neadekvatno kontrolirana šećerna bolest hiperkalijemija
English: Bradycardia
Croatian: Laktacidoza
English: STATEMENT OF ACTIVE SUBSTANCE(S)
Croatian: Nakon jednokratne peroralne primjene radioaktivno obilježenog (
English: VIAL LABEL
Croatian: NALJEPNICA NA BOČICI
English: Nasal dryness Pulmonary congestion
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja kašalj suhoća nosa kongestija pluća
English: Dyspepsia
Croatian: Proljev
English: Flushing Hot flush
Croatian: Krvožilni poremećaji navale crvenila navale vrućine (valunzi)
English: It is available as capsules (5, 20, 100, 140, 180 and 250 mg).
Croatian: Dostupan je u kapsulama (5, 20, 100, 140, 180 i 250 mg).
English: Temozolomide Teva should be taken without food.
Croatian: Temozolomide Teva treba uzimati bez hrane.
English: The full EPAR for Temozolomide Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Temozolomide Teva nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The dose of Temozolomide Teva depends on body surface area (calculated using the patient's height and weight) and ranges from 75 to 200 mg per square metre, once a day.
Croatian: Doza Temozolomide Teva ovisi o tjelesnoj površini bolesnika (izračunava se pomoću visine i tjelesne težine bolesnika) u rasponu od 75 do 200 mg po metru kvadratnom, jednom na dan.
English: It is used to treat malignant glioma (brain tumours) in the following groups of patients:
Croatian: Koristi se za liječenje malignih glioma (tumora mozga) u sljedećim grupama bolesnika:
English: • adults with newly diagnosed glioblastoma multiforme (an aggressive type of malignant glioma).
Croatian: • odraslih bolesnika s novodijagnosticiranim multiformnim glioblastomom (agresivnim tipom malignog glioma).
English: MTIC binds to the DNA of cells while they are reproducing, which stops cell division.
Croatian: MTIC se vezuje na DNK u stanicama dok se one umnožavaju, što zaustavlja diobu stanica.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Temozolomide Teva.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist davanja odobrenja za stavljanje lijeka u promet i svoje preporuke o uvjetima za primjenu lijeka Temozolomide Teva.
English: • adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment.
Croatian: • odraslih bolesnika i djece od navršene treće godine starosti s malignim gliomom, kao što je multiformni glioblastom ili anaplastični astrocitom, koji je recidivirao ili napreduje nakon standardne terapije.
English: The dose and the number of doses depend on the type of tumour being treated, whether the patient has been treated before, whether Temozolomide Teva is being used alone or with other treatments, and how the patient responds to treatment.
Croatian: Doza i broj doza ovise o tipu tumora koji se liječi, o činjenici je li bolesnik ranije primio terapiju, da li se Temozolomide Teva koristi kao monoterapija ili u kombinaciji s drugim liječenjem te kako bolesnik odgovara na liječenje.
English: Patients may also need to take medicines to prevent vomiting before taking Temozolomide Teva.
Croatian: Bolesnici će možda također trebati uzeti lijekove prije uzimanja Temozolomide Teva da bi spriječili povraćanje.
English: In the body, temozolomide is converted to another compound called MTIC.
Croatian: U tijelu se temozolomid pretvara u drugi spoj naziva MTIC.
English: The European Commission granted a marketing authorisation valid throughout the EU for Temozolomide Teva on 28 January 2010.
Croatian: Europska komisija izdala je odobrenje za stavljanje u promet koje za lijek Temozolomide Teva vrijedi na prostoru Europske unije od 28. siječnja 2010.
English: For more information about treatment with Temozolomide Teva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o terapiji lijekom Temozolomide Teva pročitajte u uputi lijeka (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: As a result, the cancer cells cannot divide, slowing down the growth of tumours.
Croatian: To rezultira nemogućnošću diobe stanica i usporavanjem rasta tumora.
English: This is a summary of the European public assessment report (EPAR) for Temozolomide Teva.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije (EPAR) o lijeku Temozolomide Teva.
English: This means that Temozolomide Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Temodal.
Croatian: To znači da je Temozolomide Teva sličan „referentnom lijeku” koji je već odobren u Europskoj uniji pod nazivom Temodal.
English: Temozolomide Teva is a ‘generic medicine'.
Croatian: Temozolomide Teva je „generički lijek”.
English: For full details, see the summary of product characteristics (also part of the EPAR).
Croatian: Potpune informacije pročitajte u sažetku opisa svojstava proizvoda (također dio EPAR-a).
English: Temozolomide Teva is used first with radiotherapy and then on its own;
Croatian: Temozolomide Teva se prvo koristi istodobno s radioterapijom (RT), a zatim kao monoterapija;
English: The CHMP concluded that, in accordance with EU requirements, Temozolomide Teva has been shown to have comparable quality and to be bioequivalent to Temodal.
Croatian: CHMP je zaključio kako je, u skladu sa zahtjevima EU-a, potvrđeno kako Temozolomide Teva posjeduje usporedivu kvalitetu te je bioekvivalentan s lijekom Temodal.
English: Because Temozolomide Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.
Croatian: Budući da je Temozolomide Teva generički lijek i bioekvivalentan je referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: What are the benefits and risks of Temozolomide Teva?
Croatian: Koje su koristi i rizici lijeka Temozolomide Teva?
English: Other information about Temozolomide Teva
Croatian: Ostale informacije o lijeku Temozolomide Teva
English: Temozolomide Teva is used on its own in these patients.
Croatian: Temozolomide Teva se koristi kao monoterapija u ovih bolesnika.
English: Temozolomide Teva temozolomide
Croatian: Temozolomide Teva temozolomid
English: Temozolomide Teva should be used with caution in patients with severe liver problems or with kidney problems.
Croatian: Temozolomide Teva treba primjenjivati oprezno u bolesnika s ozbiljnim oštećenjima jetre ili bubrega.
English: Treatment with Temozolomide Teva should be prescribed by a doctor with experience in the treatment of brain tumours.
Croatian: Liječenje lijekom Temozolomide Teva smiju propisivati samo liječnici s iskustvom u liječenju tumora mozga.
English: The Committee recommended that Temozolomide Teva be given marketing authorisation.
Croatian: Odbor je preporučio izdavanje odobrenja za stavljanje u promet lijeka Temozolomide Teva.
English: Temozolomide Teva is a medicine that contains the active substance temozolomide.
Croatian: Temozolomide Teva je lijek koji sadrži djelatnu tvar temozolomid.
English: Because Temozolomide Teva is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Temodal.
Croatian: Budući da je Temozolomide Teva generički lijek, ispitivanja na bolesnicima bila su ograničena na utvrđivanje činjenice je li riječ o bioekvivalentu referentnom lijeku Temodal.
English: The active substance in Temozolomide Teva, temozolomide, belongs to a group of cancer medicines called alkylating agents.
Croatian: Djelatna tvar lijeka Temozolomide Teva, temozolomid, ubraja se u grupu citostatika pod nazivom alkilirajući pripravci.
English: What is Temozolomide Teva?
Croatian: Što je Temozolomide Teva?
English: Why has Temozolomide Teva been approved?
Croatian: Zašto je lijek Temozolomide Teva odobren?
English: What is Temozolomide Teva used for?
Croatian: Za što se Temozolomide Teva koristi?
English: How is Temozolomide Teva used?
Croatian: Kako se Temozolomide Teva koristi?
English: How has Temozolomide Teva been studied?
Croatian: Kako je Temozolomide Teva ispitivan?
English: Therefore, the CHMP's view was that, as for Temodal, the benefit outweighs the identified risk.
Croatian: Stoga je stav Odbora kako koristi nadmašuju utvrđene rizike, kao i kod lijeka Temodal.
English: How does Temozolomide Teva work?
Croatian: Kako djeluje Temozolomide Teva?